GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
220 hedge funds and large institutions have $3.33B invested in Global Blood Therapeutics, Inc. in 2020 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 81 increasing their positions, 71 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding in top 10
Funds holding in top 10: →
23% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 43
30% less capital invested
Capital invested by funds: $4.73B → $3.33B (-$1.4B)
Holders
220
Holding in Top 10
7
Calls
$31.8M
Puts
$35.8M
Top Buyers
| 1 | +$160M | |
| 2 | +$79.4M | |
| 3 | +$50.3M | |
| 4 |
RI
RTW Investments
New York
|
+$36.8M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$31.6M |
Top Sellers
| 1 | -$59.6M | |
| 2 | -$58M | |
| 3 | -$30.8M | |
| 4 |
DM
Deerfield Management
New York
|
-$20M |
| 5 |
Two Sigma Investments
New York
|
-$13.7M |